As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas. Built from ...

Sanofi has announced a change of leadership, with former Merck KGaA chief executive Belén Garijo taking the helm of the ...

Zydus Lifesciences has reached a settlement agreement with Astellas in a patent dispute involving overactive bladder therapy Myrbetriq, which will allow its generic to remain on sale in the US.

In its main clinical trial, mRNA-1010 was shown to be 26.6% more effective than the comparator flu shot in adults aged 50 years and older. mRNA-based flu vaccines, which can be produced rapidly, have ...

PHARMAP 2026 addresses this transformation with a specialised session on patient-friendly design and its role in modern medicine. The event is scheduled for 20-21 April in Amsterdam. Trust and ...

Madrigal Pharma was the first drugmaker to bring a treatment for metabolic dysfunction-associated steatohepatitis (MASH) to ...

Cary Claiborne, CEO of Adial Pharmaceuticals, believes his company’s bet on a precision treatment for AUD, for patients with ...